Nonalcoholic steatohepatitis

16Citations
Citations of this article
119Readers
Mendeley users who have this article in their library.

Abstract

Nonalcoholic steatohepatitis (NASH) is an underdiagnosed liver disease characterised by steatosis, necroinflammation and fibrosis. This disease may eventually develop into cirrhosis and hepatocellular carcinoma. NASH is highly prevalent among obese individuals and among patients with diabetes mellitus type 2. Nonalcoholic fatty liver (NAFL), a precursor of NASH, is the main cause of elevated serum liver enzymes among the general population. Insulin resistance is a major aetiological factor in NASH. Gradual weight loss, physical exercise and drugs that improve insulin sensitivity are potential therapies. © 2004 Van Zuiden Communications B.V. All rights reserved.

Cite

CITATION STYLE

APA

Jansen, P. L. M. (2004, July). Nonalcoholic steatohepatitis. Netherlands Journal of Medicine. https://doi.org/10.33920/med-10-2311-03

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free